Events

APPLY TODAY FOR SERVIER'S 2023 GOLDEN TICKET AT LABCENTRAL!

Servier is pleased to open the call for applications for the 2023 Golden Ticket Contest to interested startups developing innovative approaches in the following discovery and early clinical areas of interest:

• Innovative therapeutic approaches in: 
  • Oncology: Cancer cell targeting (e.g., synthetic lethality, precision oncology) and immuno-oncology (e.g., tumor micro-environment, T-cell targeting)
  • Neuroscience: Rare neurological disorders (e.g., Familial Amyotrophic Lateral Sclerosis, genetically driven pediatric epilepsies) and sub-populations of neurodegenerative diseases
  • Immuno-inflammation: Autoantibody-driven autoimmune diseases and related conditions with similar pathophysiological mechanisms
• Novel modality development strategies for small molecules, biologics (including bi-specifics, ADCs) and oligonucleotides (including ASOs), as well as targeted delivery strategies (e.g., tumor-specific, CNS delivery mechanisms)
• AI/ML data-driven platforms for drug design (including oligonucleotides and antibodies) and to support translational activities (target and biomarker identification) 

How to Apply:

To apply, submit a non-confidential pitch deck highlighting your innovative approach to advancing therapies for patients with high unmet needs to: GoldenTicket@servier.com. All submissions will be reviewed. Three semi-finalists will be invited to a pitch event at LabCentral in Cambridge, MA, where the Golden Ticket winner will be announced!

Timeline:

Application submission deadline: March 10, 2023
Submission review: March 13 – April 3, 2023
Golden Ticket semi-finalists notified: April 3, 2023
Servier Golden Ticket pitch event and announcement of finalist: April 12, 2023 @ LabCentral

Disclosures: 

The winner of the “Golden Ticket” Contest shall receive a $50,000 credit towards space and services available at LabCentral 700 for use within a 13-month period, beginning upon receipt. Additional terms and conditions apply, subject to Servier and LabCentral’s discretion. All submissions shall be reviewed. Recipient shall not receive consideration in the form of cash. Recipients seeking access to, and discussions with, Servier employees in the form of guidance or feedback may be required to execute appropriate confidentiality agreements, at Servier’s discretion.

Any questions or comments regarding this contest can be directed to: GoldenTicket@servier.com